泪道激光联合迪可罗眼膏治疗泪道阻塞的研究

来源 :中国伤残医学 | 被引量 : 0次 | 上传用户:G00G01
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨泪道激光联合迪可罗眼膏治疗泪道阻塞的临床疗效。方法:采用泪道激光泪道成形术联合泪道内分别注入迪可罗眼膏和生理盐水,共治疗泪道阻塞患者106例(120只眼)。随访观察6个月。结果:迪可罗组6个月冲洗通畅率为93.3%,生理盐水组保持通畅率为70.0%,两组疗效差异有显著性(χ2=10.91,P<0.01)。结论:采用泪道激光泪道成形术联合泪道内注入迪可罗眼膏,是成功率较高的治疗泪道阻塞的方法之一。 Objective: To investigate the clinical efficacy of lacrimal laser combined with Diocola ointment in the treatment of lacrimal duct obstruction. Methods: 106 cases (120 eyes) of lacrimal duct obstruction were treated with lacrimal lacrimaloplasty combined with Diocletin ointment and normal saline respectively. Follow-up observation of 6 months. Results: The rate of patency in 6 - month group was 93.3% and the rate of patency in the group of normal saline was 70.0%. There was significant difference between the two groups (χ2 = 10.91, P <0.01). Conclusion: The lacrimal laser lacrimaloplasty combined with intraocular injection of Diochori ointment is one of the most successful methods for the treatment of lacrimal duct obstruction.
其他文献
在进行产品设计过程中,经常遇到不同产品中的同一或类似零部件被不同设计人员重复设计的问题。为提高设计效率,充分实现信息共享,设计开发了机电产品零部件库系统。本设计综
目的:探讨纳洛酮(NLX)及神经节苷脂(GM1)在重型颅脑损伤中的运用效果及其机制.方法:将76例急性重型颅脑损伤病人随机分成NLX及GM1治疗组(n=40)和对照组(n=36),观察治疗时期病
班主任作为班级的管理者与领导者,不但肩负着教书育人的重要责任,而且应时刻关注每一位学生的健康成长,以促使学生身心得到协调发展,使他们成为对社会、对国家发展有用的人才
期刊